Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
LEP methylation | 0.408 (0.206–0.807) | 0.010 | 0.371 (0.164–0.837) | 0.017 |
Age | 0.151 (0.067–0.337) | 0.000 | 0.142 (0.058–0.343) | 0.000 |
WBC | 0.284 (0.136–0.593) | 0.001 | 0.545 (0.232–1.280) | 0.164 |
Cytogenetic risks | 0.317 (0.178–0.564) | 0.000 | 0.349 (0.190–0.642) | 0.001 |
NPM1 mutations | 1.530 (0.481–4.867) | 0.472 |  |  |
FLT3-ITD mutations | 0.819 (0.219–3.071) | 0.768 |  |  |
C-KIT mutations | 2.625 (0.461–14.932) | 0.277 |  |  |
N/K-RAS mutations | 0.381 (0.098–1.487) | 0.165 |  |  |
DNMT3A mutations | 0.480 (0.089–2.581) | 0.392 |  |  |
U2AF1 mutations | Undermined | 0.999 | Â | Â |
IDH1/2 mutations | 0.827 (0.133–5.141) | 0.838 |  |  |
SRSF2 mutations | Undermined | 0.999 | Â | Â |
SETBP1 mutations | 1.255 (0.077–20.556) | 0.874 |  |  |